Rubric Capital Management LP Mereo Biopharma Group PLC Transaction History
Rubric Capital Management LP
- $2.93 Billion
- Q1 2024
A detailed history of Rubric Capital Management LP transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Rubric Capital Management LP holds 13,552,997 shares of MREO stock, worth $48.8 Million. This represents 1.52% of its overall portfolio holdings.
Number of Shares
13,552,997
Previous 13,552,997
-0.0%
Holding current value
$48.8 Million
Previous $31.3 Million
42.86%
% of portfolio
1.52%
Previous 0.7%
Shares
10 transactions
Others Institutions Holding MREO
# of Institutions
88Shares Held
85.6MCall Options Held
182KPut Options Held
249K-
Adage Capital Partners Gp, L.L.C. Boston, MA9.33MShares$33.6 Million0.06% of portfolio
-
Mangrove Partners New York, NY8.75MShares$31.5 Million3.09% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD8.14MShares$29.3 Million0.7% of portfolio
-
683 Capital Management, LLC New York, NY5.75MShares$20.7 Million1.62% of portfolio
-
Janus Henderson Group PLC London, X05.12MShares$18.4 Million0.01% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $450M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...